CBQK:QSECommercial Bank (Q.S.C.) Analysis
Data as of 2026-06-13 - not real-time
QAR 4.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock trades at QAR 4.17, sitting below its 20‑day (4.19), 50‑day (4.29) and 200‑day (4.40) moving averages, confirming a bearish technical stance. RSI at 46 and a modest bullish MACD histogram suggest limited upside momentum, while volume is on a downtrend. Nevertheless, the bank offers a 7.2% dividend yield and a payout ratio of ~65%, making it attractive for income seekers. Valuation metrics are compelling: a PE of 9× versus the industry average of 16.8× and a PB of 0.65, indicating the stock is priced well below its book value.
Fundamental concerns arise from a negative operating cash flow of QAR 3.36 bn and zero free cash flow, which casts doubt on the long‑term sustainability of the dividend despite the high yield. The balance sheet shows ample liquidity (cash QAR 14.7 bn) but a sizable debt load, and the 30‑day volatility of 18.6% combined with a beta around 0.4 points to moderate market sensitivity. Analysts’ consensus remains Buy, with a target median price near QAR 5.08, implying roughly 18% upside potential.
Fundamental concerns arise from a negative operating cash flow of QAR 3.36 bn and zero free cash flow, which casts doubt on the long‑term sustainability of the dividend despite the high yield. The balance sheet shows ample liquidity (cash QAR 14.7 bn) but a sizable debt load, and the 30‑day volatility of 18.6% combined with a beta around 0.4 points to moderate market sensitivity. Analysts’ consensus remains Buy, with a target median price near QAR 5.08, implying roughly 18% upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages indicates bearish bias
- High dividend yield attractive for income
- Decreasing volume and limited momentum
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to peers (low PE/PB)
- Target price suggests ~18% upside
- Forward PE of 6.5 indicates earnings growth expectations
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong capital base and book value per share
- Consistent profitability margins
- Attractive dividend yield despite cash flow concerns
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin53.32%
P/E Ratio9.1
ROE7.94%
ROA1.14%
P/B Ratio0.6
Op. Cash FlowQAR-3356748032
Industry P/E16.8
Technical Analysis
TrendBearish
RSI46.3
SupportQAR 4.10
ResistanceQAR 4.31
MA 20QAR 4.19
MA 50QAR 4.29
MA 200QAR 4.40
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target PriceQAR 4.94
Upside/Downside18.45%
GradeUndervalued
TypeValue
Dividend Yield7.19%
Risk Assessment
Beta-0.04
Volatility18.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.